Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

SMS Mobile Technology for Vaccine Coverage and Acceptance (Vaxtech)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01663636
Recruitment Status : Completed
First Posted : August 13, 2012
Results First Posted : December 31, 2018
Last Update Posted : December 31, 2018
Sponsor:
Information provided by (Responsible Party):
University of Colorado, Denver

Brief Summary:
To pilot test a mobile phone SMS (Short Message Service) system that will provide periodical messaging texts to mothers or custodians of infants who come for their first dose vaccines within the first 3 months of life to improve timely immunization coverage, vaccine acceptance and ensure vaccine safety monitoring. The intervention will include a "cloud-based" information system alimented by mobile phone data entry at the health post nurse level, that links child vaccination status and is able to remind parents and nurses of the need for next vaccination appointment and provide a system for reporting of adverse events following immunization in the immediate post-vaccination period.

Condition or disease Intervention/treatment
Adherence to Vaccination Schedules Behavioral: SMS message reminding mothers to come for their scheduled vaccines

  Show Detailed Description

Layout table for study information
Study Type : Observational
Actual Enrollment : 321 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: SMS Mobile Technology for Vaccine Coverage and Acceptance in Guatemalan Infants
Study Start Date : September 2012
Actual Primary Completion Date : June 2014
Actual Study Completion Date : June 2015

Group/Cohort Intervention/treatment
SMS Vaccine
Mothers will be sent an SMS message reminding them to come for their scheduled vaccines 1 week prior to the date of 2nd and 3rd doses
Behavioral: SMS message reminding mothers to come for their scheduled vaccines
Reminder

Usual care
Mothers under usual care will serve as a control



Primary Outcome Measures :
  1. Completion of 3 Doses of Pentavalent Vaccine [ Time Frame: 8 months of age ]
    Number of children vaccinated with the recommended dose of Pentavalent vaccines according to the age schedule of the National Immunization Program in Guatemala



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   1 Month to 12 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Infants under 12 months of age from Ministry of Health Clinics in Guatemala City
Criteria

Inclusion Criteria:

  • Infants 1-3 months of age coming for their 1 dose of primary vaccines

Exclusion Criteria:

  • Received 1 dose of vaccines, excluding BCG
  • No mobile phone with SMS or unable to use SMS at home
  • Intent to move from the clinic area in the next 6 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01663636


Locations
Layout table for location information
Guatemala
University del Valle
Guatemala, Guatemala, 01001
Sponsors and Collaborators
University of Colorado, Denver
Investigators
Layout table for investigator information
Principal Investigator: Edwin J Asturias, MD University of Colorado School of Medicine
Study Director: Ingrid L Contreras-Roldan, MD University del Valle, Guatemala

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT01663636     History of Changes
Other Study ID Numbers: 12-1144
OPP1061430 ( Other Identifier )
First Posted: August 13, 2012    Key Record Dates
Results First Posted: December 31, 2018
Last Update Posted: December 31, 2018
Last Verified: June 2018
Keywords provided by University of Colorado, Denver:
vaccines
SMS
mobile phones
Additional relevant MeSH terms:
Layout table for MeSH terms
Vaccines
Immunologic Factors
Physiological Effects of Drugs